NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...
As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...
Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...
Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...
Scientists have identified two previously unknown biological subtypes of multiple sclerosis (MS) using artificial ...
Verywell Health on MSN
How multiple sclerosis is treated
Medically reviewed by Brigid Dwyer, MD Key Takeaways Disease-modifying therapies slow down the progression of multiple ...
NEW HAVEN, Conn. (WTNH) — Even though multiple sclerosis, also known as MS, is a chronic lifelong disease, there are ways to manage and treat it. Recently, the FDA approved a new drug, Tyruko, ...
Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...
BARCELONA, Spain — In a noninferiority trial in pediatric-onset multiple sclerosis (POMS), ocrelizumab met its primary endpoint compared with fingolimod, demonstrating better tolerability and greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback